Element Capital Management LLC Clovis Oncology, Inc. Transaction History

Element Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$42.06 - $62.4 $3.58 Million - $5.31 Million	-85,069 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $4.14 Million - $5.59 Million	-82,580 Reduced 49.26%	85,069 $4.49 Million
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $9.67 Million - $14.2 Million	167,649	167,649 $11.4 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.